Food and Drug Regulations, C.R.C., c. 870

Section C.08.003.01

Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.08.003.01 · current to June 17, 2026 · regulation last amended June 17, 2026

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) The following definitions apply in this section. submission means (a) a new drug submission that is filed under section C.08.002; (b) an extraordinary use new drug submission that is filed under section C.08.002.01; (c) an abbreviated new drug submission that is filed under section C.08.002.1; or (d) an abbreviated extraordinary use new drug submission that is filed under section C.08.002.1. (présentation) supplement means a supplement to a submission that is filed under section C.08.003. (supplément) (2) Despite sections C.08.002, C.08.002.01, C.08.002.1 and C.08.003 and subject to subsection (3), the manufacturer of a new drug is not permitted to file a submission or supplement for the new drug on the basis of a direct or indirect comparison to any new drug in respect of which an authorization was issued under the ISAD Interim Order. (3) Subsection (2) does not prevent the manufacturer of a new drug from filing a submission or supplement for the new drug on the basis of a direct or indirect comparison to another new drug in respect of which an authorization was issued under the ISAD Interim Order if (a) a notice of compliance is issued under section C.08.004 or C.08.004.01 in respect of a submission or supplement for that other new drug; and (b) the comparison is in respect of the matters that were approved by the notice of compliance.
Read the Food and Drug Regulations on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.